#Plasmid_DNA
Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033#USA#gene_therapy#Portland#Plasmid_DNA#viral_vectors
Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033
The global market for viral vectors and plasmid DNA manufacturing is set to reach $34 billion by 2033, driven by growth in gene therapy and rising disease prevalence.
third-news.com
February 23, 2026 at 3:42 PM
Bionova Scientific and Syenex Form Alliance for Enhanced Gene Therapy Deliveries#United_States#Houston#Syenex#Bionova_Scientific#Plasmid_DNA
Bionova Scientific and Syenex Form Alliance for Enhanced Gene Therapy Deliveries
Bionova Scientific and Syenex have teamed up to enhance global access to high-quality plasmid DNA, pivotal for advanced gene therapies.
third-news.com
January 8, 2026 at 4:51 PM
VGXI Achieves Key FDA Inspection Success, Boosting Plasmid DNA Manufacturing Leadership#USA#Plasmid_DNA#VGXI_Inc#Biologics_License_Application#Conroe
VGXI Achieves Key FDA Inspection Success, Boosting Plasmid DNA Manufacturing Leadership
VGXI, a leader in plasmid DNA biopharmaceuticals, marks a significant achievement with FDA approval for a client's BLA following a successful inspection.
third-news.com
May 12, 2025 at 3:08 PM
ProBio Introduces Innovative GMP Plasmid DNA Manufacturing Services for Biopharma#USA#ProBio#Hopewell#Plasmid_DNA#GMP_Manufacturing
ProBio Introduces Innovative GMP Plasmid DNA Manufacturing Services for Biopharma
ProBio's latest GMP Plasmid DNA service ensures fast delivery and high quality, drastically reducing timelines for clinical development. Read more!
third-news.com
April 9, 2025 at 10:45 AM